Discover trends, market shifts, and competitive outlooks for the cellular immunotherapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Cellular Immunotherapy Market Expected to Grow Between 2025 And 2029?

The size of the cellular immunotherapy market has seen a quick expansion in the past few years. The market, which stands at $5.72 billion in 2024, is expected to increase to $6.61 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.7%. The expansion during the historic period can be associated with advancements in cancer treatment, clinical triumphs, regulatory endorsements, and an escalating incidence of targeted diseases.

The market size of cellular immunotherapy is predicted to witness exponential growth over the next few years. It’s estimated that by 2029, the market will be valued at $11.27 billion with a CAGR of 14.2%. The anticipated growth during this forecasted period can be linked to the expansion to solid tumors, enhancements in manufacturing, healthcare infrastructure, and funding for research. Key trends during the forecast period include investments in research and development, data from clinical trials, and combination therapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3435&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Cellular Immunotherapy Market?

The expected expansion of the cellular immunotherapy market is largely down to advanced research and the success of clinical trials in cellular immunotherapy. Companies are shifting their focus towards crafting new cellular immunotherapies to address various diseases. In an example reported by the Cancer Research Institute, a solo-operating nonprofit based in the US working towards the creation of immunotherapy for prohibiting, treating, and ultimately wiping out every form of cancer globally, there were 2,756 active cell therapy drugs as of April 2022 in the worldwide immuno-oncology pipeline. This is a 36% increase from the 2021 landscape analysis record of 2,031, albeit with a slight drop from the previous year’s growth rate of 43%. An accelerated pace of development was observed in cellular immunotherapy in both clinical and preclinical stages in 2020, compared to 2019, which is expected to widen the cellular immunotherapy landscape. This, in turn, is projected to boost revenues, contributing to the growth of the cellular immunotherapy market.

Which Segments in the Cellular Immunotherapy Offer the Most Growth?

The cellular immunotherapy market covered in this report is segmented –

1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy

2) By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications

3) By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications

Subsegments:

1) By Tumour-Infiltrating Lymphocyte (TIL) Therapy: Autologous TIL Therapy, Allogeneic TIL Therapy, Other TIL Therapy

2) By Engineered T Cell Receptor (TCR) Therapy: Alpha-Beta TCR Therapy, Gamma-Delta TCR Therapy, Other Engineered TCR Therapy

3) By Chimeric Antigen Receptor (CAR) T Cell Therapy: Autologous CAR T Cell Therapy, Allogeneic CAR T Cell Therapy, CAR T Cell Therapy For Solid Tumors, CAR T Cell Therapy For Hematologic Malignancies, Other CAR T Cell Therapy

4) By Natural Killer (NK) Cell Therapy: Autologous NK Cell Therapy, Allogeneic NK Cell Therapy, NK Cell Therapy With Engineered Modifications, Other NK Cell Therapy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3435&type=smp

What Are the Fastest-Growing Geographies in the Cellular Immunotherapy Market?

North America was the largest region in the cellular immunotherapy market in 2023. The regions covered in the cellular immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Cutting-Edge Market Trends Are Expected to Drive the Cellular Immunotherapy Market’s Growth?

Firms operating within the cellular immunotherapy sector are prioritizing the creation of off-the-shelf allogeneic treatments as a fresh and superior solution for cancer. These therapies, unlike autologous therapy, are generated using donor cells rather than the patient’s own cells. These non-customized treatments offer several benefits like cost-effectiveness, mass scale, rapid production, and quality management. In fact, Novartis AG, a pharmaceutical corporation situated in Switzerland that focuses on the research, development, manufacture, and marketing of medications, stated in May 2022 that the US Food and Drug Administration (FDA) has hastily approved Kymriah (tisagenlecleucel) for the treatment of adult patients with relapsed or refractory (r/r) follicular lymphoma (FL) after undergoing at least two systemic therapy lines. Furthermore, Acepodia, an American next-generation cell immuno-technology firm, plans to commence a phase 1 clinical trial in August 2020 to analyze ACE1702, an allogeneic, off-the-shelf NK cell therapy, in treating solid tumors.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

What Are the Key Elements That Define the Cellular Immunotherapy Market?

Cellular immunotherapy refers to a sort of immunotherapy in which a patient receives T cells, an immune cell, to aid the body in fighting diseases like cancer. It is a cutting-edge kind of treatment that uses the body’s immune system to combat cancer.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3435

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model